These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23999684)
1. Cryptogenic cirrhosis is the leading cause for listing for liver transplantation in Sri Lanka. Siriwardana RC; Niriella MA; Liyanage CA; Wijesuriya SR; Gunathilaka B; Dassanayake AS; De Silva HJ Indian J Gastroenterol; 2013 Nov; 32(6):397-9. PubMed ID: 23999684 [TBL] [Abstract][Full Text] [Related]
2. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016. Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in Sri Lanka. Bulathsinhala BKS; Siriwardana RC; Gunetilleke MB; Niriella MA; Dassanayake A Ceylon Med J; 2018 Sep; 63(3):133-138. PubMed ID: 30415518 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related]
6. Histopathological Examination of Explanted Liver After Transplantation in Patients With Cryptogenic Cirrhosis. Tardu A; Karagul S; Yagci MA; Ertugrul I; Sumer F; Kirmizi S; Yaylak F; Koc C; Hatipoglu S; Kayaalp C; Yilmaz S Transplant Proc; 2015 Jun; 47(5):1450-2. PubMed ID: 26093740 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka. Dassanayake AS Euroasian J Hepatogastroenterol; 2018; 8(1):69-72. PubMed ID: 29963467 [TBL] [Abstract][Full Text] [Related]
8. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. Thuluvath PJ; Hanish S; Savva Y Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186 [TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis. Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413 [TBL] [Abstract][Full Text] [Related]
11. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis. Yaghobi R; Kazemi MJ; Geramizadeh B; Malek Hosseini SA; Moayedi J Exp Clin Transplant; 2020 Apr; 18(2):206-209. PubMed ID: 30346262 [TBL] [Abstract][Full Text] [Related]
12. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468 [TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis. Thuluvath PJ; Hanish S; Savva Y Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462 [TBL] [Abstract][Full Text] [Related]
14. Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study. Senanayake SM; Niriella MA; Weerasinghe SK; Kasturiratne A; de Alwis JP; de Silva AP; Dassanayake AS; de Silva HJ BMC Res Notes; 2012 Dec; 5():663. PubMed ID: 23198995 [TBL] [Abstract][Full Text] [Related]
15. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome. Marmur J; Bergquist A; Stål P Scand J Gastroenterol; 2010; 45(1):60-9. PubMed ID: 20030578 [TBL] [Abstract][Full Text] [Related]
18. Sero-prevalence and vaccination status of hepatitis A and hepatitis B among adults with cirrhosis in Sri Lanka: a hospital based cohort study. Niriella MA; Kobbegala VJ; Karalliyadda HN; Ranawaka CK; de Silva AP; Dassanayake AS; de Silva HJ BMC Res Notes; 2017 Jul; 10(1):303. PubMed ID: 28732527 [TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for cryptogenic cirrhosis. Charlton MR; Kondo M; Roberts SK; Steers JL; Krom RA; Wiesner RH Liver Transpl Surg; 1997 Jul; 3(4):359-64. PubMed ID: 9346764 [TBL] [Abstract][Full Text] [Related]
20. Outcome after liver transplantation for NASH cirrhosis. Malik SM; deVera ME; Fontes P; Shaikh O; Ahmad J Am J Transplant; 2009 Apr; 9(4):782-93. PubMed ID: 19344467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]